TABLE 5 ] .
ORs for Associations of Baseline Characteristics and > 10% Emphysema on CT Among Participants With HIV Infection
| OR (95% CI) for > 10% Emphysema | ||
| Characteristic | Unadjusted | Adjusteda |
| Nadir CD4 < 200 cells/μL | 2.39 (1.02-5.62)b | 2.98 (1.14-7.81)b |
| sCD14, upper 25th percentile | 3.95 (1.20-12.9)b | 2.55 (1.04-6.22)b |
| IL-6, upper 25th percentile | 0.77 (0.32-1.85) | … |
| D-dimer, upper 25th percentile | 2.02 (0.86-4.76) | … |
| ART use | 0.82 (0.18-3.66) | … |
| Recent CD4 < 200 cells/μL | 2.27 (0.77-6.64) | … |
| Detectable HIV RNA | 1.37 (0.53-3.56) | … |
| History of pneumonia | 2.45 (1.04-5.74)b | … |
| Agec | 2.19 (1.23-3.92)b | … |
| Male sex | 1.00 (0.09-11.5) | … |
| Race | ||
| Black | Reference | … |
| White | 1.52 (0.56-4.13) | … |
| Hispanic/other | 0.25 (0.05-1.17) | … |
| Cigarette smoking (pack-y)d | 1.24 (1.02-1.51)b | 1.29 (1.05-1.59)b |
| Smoking status | ||
| Never smoker | Reference | … |
| Former smoker | 7.00 (0.77-63.8) | … |
| Current smoker | 10.9 (1.36-87.8)b | … |
| Smoking marijuana | 4.13 (0.88-19.3) | … |
| Injection drug use | 1.11 (0.47-2.60) | … |
See Table 1 legend for expansion of abbreviations.
a
This final multivariable model includes 111 participants (97% of the analytic cohort with HIV infection).
b
P < .05.
c
10-y increments.
d
Increments of 10 pack-y.